Sexually Transmitted Diseases (STDs)

STD Related Topics

Subscribe to STD News Updates
Get an e-mail alert when news links are posted.

STD News

	2010 STD Surveillance Statistics Reports, graphs, tables and text providing a description of the STD epidemic in Minnesota in 2010. Recording and presentation materials from the release webinar are also now available. 2011 data will be released on April 19, 2012.

NEW!	HIV/AIDS among Men Who Have Sex with Men in Minnesota Men who have sex with men (MSM) and men who have sex with men and use injection drugs (MSM/IDU) remain at increased risk for HIV infection in MN.

	Food and Drug Administration - Fraudulent Products: Sexually Transmitted Diseases (STDs) Important information on bogus STD treatments

	MDH Launches Sexual Health Site Sexual health is a state of physical, emotional, mental and social well being in relation to sexuality; it is not merely the absence of disease, dysfunction or infirmity. Sexual health requires a positive and respectful approach to sexuality and sexual relationships, as well as the possibility of having pleasurable and safe sexual experiences, free of coercion, discrimination and violence.

	Survey Results: The Use of Expedited Partner Therapy (EPT) in Minnesota Results are now available of an evaluation survey conducted by MDH in 2010 to determine the extent to which EPT is currently being used in Minnesota, as well as to identify challenges and successes that have been experienced and technical assistance needs related to implementing EPT.

	Dear Colleague Letter Azithromycin resistance in Hawaii (May 24, 2011)

	2010 HIV/AIDS Surveillance Reports Number and demographic characteristics of newly diagnosed HIV/AIDS cases in Minnesota. Recording and presentation materials from the release webinar are also now available.

	The Minnesota Chlamydia Strategy: Action Plan to Reduce and Prevent Chlamydia in Minnesota The Minnesota Chlamydia Partnership (MCP) and the STD and HIV Section of the Minnesota Department of Health (MDH) present the Strategy for Reducing and Preventing Chlamydia in Minnesota, the first-ever action plan to address the epidemic of the sexually transmitted disease chlamydia.

	Proposed Amendment to the Communicable Disease Reporting Rule (HIV) The Minnesota Department of Health is considering an amendment to the Communicable Disease Reporting Rule, Minnesota Rules, Chapter 4605. The change would require all laboratories to report to the Minnesota Department of Health the results of all CD4+ lymphocyte counts and percents and the results of all HIV viral detection laboratory tests.

	Dear Collegue Letter (PDF: 32KB/1 page) The Minnesota Department of Health (MDH) requests that you take a sexual history screen for syphilis, provide prevention counseling, and solicit partners when appropriate for all your male patients in light of an alarming 87 percent increase in early syphilis cases. Dated 02/2010.

	The MMWR of the 2010 STD Treatment Guidelines published electronically on December 17, 2010 contains incorrect dosage information. MMWR will issue an erratum by January 14, 2011. Three significant corrections pertain to the recommended regimens for gonococcal infections, which include gonococcal dual therapy, and the alternative regimens for bacterial vaginosis. Corrected pages to the print version (pages 50, 51, and 57) of the MMWR are available on the CDC Division of STD Prevention website at http://www.cdc.gov/std/treatment/2010/.

	CDC’s 2010 STD Treatment Guidelines for the treatment of persons who have or are at risk for sexually transmitted diseases (STDs). 2010 STD Treatment Guidelines: http://www.cdc.gov/std/treatment/2010/ A webinar for health professionals about the updated treatment guidelines is scheduled for January 13, 2011 at 2:00pm ET 2010 Treatment Guidelines Webinar: http://www.stdhivtraining.org/presentation_description.html?id=24

	Dear Collegue Letter (PDF: 33KB/1 page) The Minnesota Department of Health (MDH) would like to alert you to a 31 percent increase in new syphilis cases for 2010 compared to the same time period last year. Dated 9/27/2010. (PDF: 33KB/1 page)

	Epidemiological Profile of HIV/AIDS in Minnesota The epidemiological (epi) profile presents data on the HIV epidemic in the state of Minnesota. The profile is intended to give the Community Cooperative Council on HIV/AIDS Prevention (CCCHAP) and the Minnesota HIV Services Planning Council (Planning Council).

	The Minnesota Chlamydia Partnership (MCP) A Summit on Chlamydia was held on Tuesday, August 3, 2010 to kick-off the MCP. Professional and community experts describe the epidemic of chlamydia and discuss the complex issues surrounding it.

	Syphilis and Men Who Have Sex with Men (MSM) - 2009 Data (PDF: 114KB/20 pages) Efforts must continue to stop early syphilis increases among MSM

	Expedited Partner Therapy (EPT) information

	CDC HIV/AIDS Update: H1N1 and Adults and Adolescents Infected with HIV: Considerations for Clinicians CDC has published interim guidance for clinicians regarding management of patients with HIV who have been exposed to or who have contracted H1N1 influenza.

	April is National STD Awareness Month

	STD/HIV Laboratory Survey In 2008, MDH conducted a survey of 120 laboratories to assess STD testing and reporting practices. The results for chlamydia, gonorrhea, syphilis and HIV testing and reporting practices from survey respondents are now available.

	CDC National HIV Incidence Estimates: Frequently Asked Questions

	Fluoroquinolones No Longer Recommended to Treat Gonorrhea MDH no longer recommends the use of fluoroquinolones (e.g. ciprofloxacin) for the treatment of gonococcal infections. MDH lab surveillance data from 2007 indicate high prevalence of quinolone resistance in isolates from heterosexuals (4.5%) as well as gay/bisexual men (28%). MDH Dear Colleage Letter on Gonorrhea Treatment, June 2008 (PDF: 39KB/1 page) CDC’s Gonorrhea Treatment Guidelines Attention: Non-MDH web link.

	Now Available from Lupin Pharmaceuticals: Cefixime (Suprax®) 400 mg Tablets for Treatment of Gonorrhea The CDC has announced the availability of oral cefixime (Suprax®) tablets from Lupin Pharmaceuticals for the treatment of uncomplicated urogenital and rectal gonococcal infections. This is the only CDC-recommended gonorrhea treatment available as a single-dose tablet. Link to MMWR Attention: Non-MDH web link. CDC Dear Colleague Letter (PDF: 52KB/1 page) Information on obtaining cefixime tablets is available from Lupin by telephone (866-587-4617). MDH Dear Colleage Letter on Gonorrhea Treatment, June 2008 (PDF: 39KB/1 page)

	FDA Warning: Unapproved Over The Counter Drugs Marketed for Prevention and Treatment of STDs FDA issued Warning Letters to six U.S. companies and one foreign individual for marketing unapproved and misbranded drugs over the internet to U.S. consumers for the prevention and treatment of sexually transmitted diseases (STDs). [Posted 03/06/2008]

	Chlamydia Screening and CDC Treatment Recommendations

	Online syphilis training module We are now offering an online training for clinicians. CMEs are available.

	Hepatitis B ECHO-TV Program Videos available in seven languages with information on hepatitis B awareness and prevention

	Resources for Teachers/Educators Find links and tools specifically for teachers or educators.

	HIV/STD/Hepatitis Risk Assessment MDH's integrated risk assessment tool for health and social service providers.

	National and State HIV/STD Campaigns and Observances Pages contain calendar of events and materials to assist with the planning and hosting of community events.
	World AIDS Day: December 1 National Black HIV/AIDS Awareness Day: February 7 National Women and Girls HIV/AIDS Awareness Day: March 10 National Native HIV AIDS Awareness Day: March 21 National STD Awareness Month: April Hepatitis Awareness Month: May National Asian and Pacific Islander HIV/AIDS Awareness Day: May 19 National HIV Testing Day: June 27 National Latino AIDS Awareness Day: October 15 African World AIDS Day: December 9
	Content Notice: This site contains HIV or STD prevention messages that may not be appropriate for all audiences. Since HIV and other STDs are spread primarily through sexual practices or by sharing needles, prevention messages and programs may address these topics. If you are not seeking such information or may be offended by such materials, please exit this web site.